Smith Group Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
2017
Q2
$1.02M Buy
2017
Q1
$545K Sell
2016
Q4
$316K Buy
2016
Q3
$391K Buy
2016
Q2
$348K Sell
2016
Q1
$324K Sell
2015
Q4
$439K Buy